MedTrace Logo

Family Motivational Intervention in Schizophrenia

NCT01167556 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2010-07-22

No results posted yet for this study

Summary

Cannabis use by people with schizophrenia is associated with family distress and poor clinical outcomes. Therefore, an Family Motivational Intervention (FMI) was developed to help parents to motivate their child with a diagnoses of recent-onset schizophrenia to reduce cannabis use.

In a single-blind randomised clinical trail with 75 patients with the diagnosis of schizophrenia, parents will be assigned to either FMI or to routine care. Assessments will be conducted at baseline and at a 10- and 22-month follow-up. The study hypothesis is that FMI will be more effective than routine care in reducing (a) cannabis use in patients and (b) distress and sense of burden in parents.

Conditions

Interventions

BEHAVIORAL

Family Motivational Intervention

A intervention with provided parents 6 sessions of Interaction Skills training and 6 sessions Motivational Interviewing training.

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Gerard Schippers, Prof. dr. · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Don Linszen, Prof.dr. · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Lieuwe de Haan, Dr. · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2010-08-31
Completion
2011-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01167556 on ClinicalTrials.gov